AI Analysis AI Analysis of RPRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RPRX to Watchlist?
Some Reasons Why To Add RPRX:
  • High gross margin of 100.0%
  • Excellent financial health (Piotroski 7/9)
  • Strong operating margin of 67.9%
PDF

Royalty Pharma plc stock price down 0.322% on Friday
(Updated on Jul 24, 2026)

Buy candidate since Jun 22, 2026 Gain 9.82%

The Royalty Pharma plc stock price fell by -0.322% on the last day (Friday, 24th Jul 2026) from $59.02 to $58.83. During the last trading day the stock fluctuated 2.07% from a day low at $58.51 to a day high of $59.72. The price has risen in 6 of the last 10 days and is up by 4.25% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -46 thousand shares and in total, 2 million shares were bought and sold for approximately $124.36 million.

The stock lies in the upper part of a strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $59.16 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 16.42% during the next 3 months and, with a 90% probability hold a price between $65.48 and $68.87 at the end of this 3-month period.

RPRX Signals & Forecast

The Royalty Pharma plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $58.43 and $56.20. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 23, 2026, and so far it has fallen -0.322%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Royalty Pharma plc stock

Royalty Pharma plc finds support from accumulated volume at $56.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.21 (2.07%) between high and low. For the last week, the stock has had daily average volatility of 2.16%.

Our recommended stop-loss: $56.51 (-3.94%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (RPRX) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Royalty Pharma plc to open at $59.02, and during the day (based on 14 day Average True Range), to move between $58.16 and $59.50, which gives a possible trading interval of +/-$1.35 (+/-2.32%) up or down from last closing price. If Royalty Pharma plc takes out the full calculated possible swing range there will be an estimated 2.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $59.02 (0.32%) than the support at $56.23 (4.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Dividend Warning For RPRX

Dividend coming up for RPRX: Ex-dividend date (Friday 14th August, 2026) is 19 days away. The dividend is $0.240.

Is Royalty Pharma plc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Royalty Pharma plc stock to perform well in the short-term.

Current score: 4.131 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $59.02 ( 0.323%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RPRX Performance

Trading levels for RPRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 60.23 2.38%
R2 59.77 1.59%
R1 59.48 1.11%
Price 58.83
S1 58.56 -0.463%
S2 58.27 -0.95%
S3 57.81 -1.73%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 59.02 0.323%
Price 58.83
S1 56.23 -4.42%
S2 55.76 -5.22%
S3 52.96 -9.98%

RPRX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 17, 2026 Aug 14, 2026 Sep 10, 2026 $0.235 0.400%
2 Apr 17, 2026 May 15, 2026 Jun 10, 2026 $0.235 0.477%
3 Jan 09, 2026 Feb 20, 2026 Mar 10, 2026 $0.235 0.584%
4 Oct 17, 2025 Nov 14, 2025 Dec 10, 2025 $0.220 0.601%
5 Jul 18, 2025 Aug 15, 2025 Sep 10, 2025 $0.220 0.617%

FAQ

What is the symbol for Royalty Pharma plc Stock and on which exchange is it traded?
The symbol for Royalty Pharma plc is RPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Royalty Pharma plc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Royalty Pharma plc stock to perform well in the short-term.

How to buy Royalty Pharma plc Stock?
Royalty Pharma plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Royalty Pharma plc Stock.

What's the current price of Royalty Pharma plc Stock?
As of the end of day on the Jul 24, 2026, the price of an Royalty Pharma plc (RPRX) share was $58.83.

What is the 52-week high and low for Royalty Pharma plc Stock?
The 52-week high for Royalty Pharma plc Stock is $59.72 and the 52-week low is $34.08.

What is the market capitalization of Royalty Pharma plc Stock?
As of the Jul 24, 2026, the market capitalization of Royalty Pharma plc is 25.304B.

When is the next earnings date for Royalty Pharma plc?
The upcoming earnings date for Royalty Pharma plc is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ROYALTY PHARMA PLC
Royalty Pharma
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pha...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE